What is Cellivate Technologies?
Cellivate Technologies is at the forefront of developing sustainable, animal-free alternatives for cell culture, a critical component in industries such as pharmaceuticals, skincare, and food production. Their flagship product, Booster, offers a cruelty-free substitute for Fetal Bovine Serum, enhancing cell proliferation and supporting advanced applications in drug discovery and regenerative medicine. The company's commitment to quality and sustainability aids businesses in their transition to ethical and environmentally conscious practices, leveraging cutting-edge technology to provide reliable, high-performance solutions.
How much funding has Cellivate Technologies raised?
Cellivate Technologies has raised a total of $1M across 1 funding round:
Angel/Seed
$1M
Angel/Seed (2024): $1M with participation from We Founder Circle, Venture Catalysts Uttar Pradesh, Hatcher, and Antler
Key Investors in Cellivate Technologies
We Founder Circle
We Founder Circle is a global network of successful founders and angel investors providing seed funding and business development support to early-stage startups, with a sector-agnostic approach.
Venture Catalysts Uttar Pradesh
Venture Catalysts is a prominent Indian incubator and venture capital firm that supports early-stage startups through funding, mentoring, and network access, aiming to foster a comprehensive entrepreneurial ecosystem.
Hatcher
Hatcher+ utilizes an AI-driven platform, FAAST Funds As A Service Technology, to assist investors in building larger and more effective portfolios through advanced technology solutions.
What's next for Cellivate Technologies?
With this substantial enterprise-level funding, Cellivate Technologies is poised to scale its operations and further penetrate markets seeking ethical and sustainable cell growth solutions. The strategic investment signals strong confidence from backers in the company's technology and its potential to disrupt traditional supply chains reliant on animal-derived components. Future growth is expected to focus on expanding product applications, enhancing manufacturing capabilities, and solidifying partnerships within the pharmaceutical and biotechnology sectors, driving innovation in cruelty-free research and development.
See full Cellivate Technologies company page
